Chapter 7: Achievements and limitations of cervical cytology screening.
about
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essentialSingle nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control studyEffectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.Using biomarkers as objective standards in the diagnosis of cervical biopsies.The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.Human papillomavirus-related diseases in HIV-infected individualsProgram spending to increase adherence: South African cervical cancer screeningCervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Côte d'Ivoire, West Africa.The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results.Improving cervical cancer screening rates in an urban HIV clinic.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisAbnormal anal cytology in HIV-infected women.Risk factors for nonadherence with Pap testing in HIV-infected women.Good agreements between self and clinician-collected specimens for the detection of human papillomavirus in Brazilian patients.Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected womenHow protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case.Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)Lower cost strategies for triage of human papillomavirus DNA-positive women.Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceHuman papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study.Global challenges of implementing human papillomavirus vaccines.The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.Screening of cervical cancer in Catalonia 2006-2012.Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.The Prevalence of Human Papilloma Virus (HPV) in Women using Liquid Base Pap Smear in Rasht, Northern of Iran.A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.Optimizing technology for cervical cancer screening in high-resource settings.Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.HPV and cervical cancer: screening or vaccination?Development and characterization of the cobas human papillomavirus test.Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.Cervical cancer prevention--cervical screening: science in evolution.Different cervical cancer screening approaches in a Chinese multicentre study.Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.Cervical and female breast cancers in the Americas: current situation and opportunities for action.Modeling cervical cancer prevention in developed countries.Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
P2860
Q26828741-D6D567BA-5CB8-41FF-A792-99AE5DA18C73Q28384976-FD7B22B5-FCA5-457D-B44D-82B091C39AF7Q30278596-2D447FC6-5C2D-4480-BED5-435B5D5D5F01Q30431203-25561BCB-09E6-4F29-8330-DC17C64F9737Q30450948-5B27B74E-096C-4E6F-A5BC-4D301BDC5BC0Q33395603-96EC40A9-FAAC-4FEA-88F0-0EB34C7CC59FQ33459276-07C5B3E8-08DA-4BA6-BF93-499EFFC9CD60Q33575729-AFF55EB3-D824-4DA7-85F8-980F8FC168F3Q33585203-DBCF8D82-5B35-486A-8903-345BB9061569Q33784743-9F424211-B103-4101-B56A-86D5671A561BQ33883532-0CADD73F-9B81-4850-B873-D66060C18A9EQ33976403-0A8499DB-0A40-48D6-A049-C26D4EC1ED8AQ34006364-A0E49919-2495-48F3-ABF5-C2D195EDFBA6Q34040612-31314124-4800-41C3-83E4-2BD730606EB1Q34091664-7DAC2218-4C4C-4EC9-9450-E5E0BE926A28Q34174619-1BA49E3E-B8B6-4BC3-B8B3-19995F5A491FQ34286142-CBB6395B-12F6-476A-9C6F-B2D1B9960218Q34516596-372A316C-5763-4640-962F-7FB01EA1E398Q34850316-F2894A30-347C-4B69-8727-4E2B07842A61Q35037303-7E41722B-5616-4509-A306-5AFD8F427E07Q35128768-6897785B-1E1C-45AC-B7C7-CD1C4FB3A68FQ35164587-EFB4D364-4F33-4C90-A28E-C4813D83C50FQ35518164-405F8E4E-D9BB-4792-9C44-E9BC094AD27CQ35605626-8CD9ED66-CE39-4CE2-BD27-7BB8A5DF55DAQ35768821-6A6C733B-94B9-4CC2-AA7C-F9A8A2372F7FQ36045104-F1B36C97-2556-4B75-B833-C82FF8C5C392Q36068109-86A6539D-30F3-420A-AAC8-2C5FBF98BFB0Q36169189-D91BC927-124B-4C54-AF26-989A28570E4CQ36319941-5C8FA5A3-08B4-4457-AC8D-897FB96F81B9Q36404994-6DCE11EA-F639-4EF6-ACB6-24CFF9C924ACQ36608826-BEFB0401-E137-42E3-B179-75E3DB5810EFQ36826712-395040A9-E560-434F-8C19-205CFAA8107BQ37011809-B4EC7CD5-B8DE-4D50-8199-EB87485E998DQ37025594-2C481C40-9625-4BDF-B369-836012BB7966Q37135268-08C5F369-A8EC-4FB9-8E90-4B3B7F60E85FQ37195121-FBF62A24-D3B9-4338-9FEC-C5D99E402D70Q37214460-0A8FFDE1-BD8C-4FC2-B8D4-3632E2E7869AQ37291448-A67808E4-EC0B-4E33-B6F7-22923FAEBED4Q37355500-365C843F-203C-42BB-A3DB-314E9A1C3F79Q37398007-7A8DA923-4E5C-4DFA-9DCC-4D1D70C7E0E1
P2860
Chapter 7: Achievements and limitations of cervical cytology screening.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chapter 7: Achievements and limitations of cervical cytology screening.
@ast
Chapter 7: Achievements and limitations of cervical cytology screening.
@en
type
label
Chapter 7: Achievements and limitations of cervical cytology screening.
@ast
Chapter 7: Achievements and limitations of cervical cytology screening.
@en
prefLabel
Chapter 7: Achievements and limitations of cervical cytology screening.
@ast
Chapter 7: Achievements and limitations of cervical cytology screening.
@en
P2093
P1433
P1476
Chapter 7: Achievements and limitations of cervical cytology screening.
@en
P2093
Henry C Kitchener
J Thomas Cox
Philip E Castle
P304
P356
10.1016/J.VACCINE.2006.05.113
P407
P478
24 Suppl 3
P577
2006-08-01T00:00:00Z